Treating physician and research fellowDepartment of Internal Medicine III, Ulm UniversityUlm, Germany
n/a
(1541946) Endpoint Surrogacy in Chronic Lymphocytic Leukemia: A Pooled Analysis of the German CLL Study Group
Sunday, October 8, 20239:15 AM – 9:25 AM EDT
(1554032) Bendamustine, Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of the CLL2-BAAG Trial of the German CLL Study Group (GCLLSG)
Sunday, October 8, 20232:55 PM – 3:05 PM EDT
(1548000) Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with targeted drugs: pooled analysis of clinical trials from the German CLL Study Group (GCLLSG).
Monday, October 9, 202311:15 AM – 11:25 AM EDT